HSS/ Horizon Scanning for Covid19
Project leaders: Claudia Wild
Project team: All employees of the AIHTA
Coordination (vaccinations): Gregor Götz
Coordination (drugs): Sarah Wolf
Duration: March 2020 – open
Language: English and German
Publication: Policy Brief No. 002: http://eprints.aihta.at/1234/
Project objective: The establishment of a HSS/ Horizon Scanning System for Covid19 interventions has the intentions of informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and to monitor them over the next few months in order to support evidence-based purchasing if necessary.
Methods: Based on international sources (information gathered by the WHO, preliminary work by other international institutions, publications) first selective searches by means of searches in study registries are carried out for information on clinical studies in humans and the state of research. Thereafter “vignettes” (short descriptions) are developed for those products that are already in an "advanced" stage. Subsequently, the products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.
All work steps are conducted in close international (European) cooperation.
Work steps (and scheduling)
Tasks |
Scheduling |
Contacting cooperation networks |
until April 3rd 2020 |
Overview tables on products under development |
until April 3rd 2020 |
Prioritization according to the state of clinical research |
until April 3rd 2020 |
Vignettes for prioritized products |
permanently ongoing |
Creating a "Living Document“ |
1st report: April 14th |
Product monitoring |
until further notice |